Validate Gene Expression and Proteomic Signatures Predictive of Treatment for Response for Breast Cancer Patient
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Adriamycin|DRUG: Docetaxel
Sponsor: National University Hospital, Singapore